APA (7th ed.) Citation

Abdel Jawad, M., Furtado, R. H. M., Esterline, R., Oscarsson, J., Gasparyan, S. B., Koch, G. G., . . . Maia, L. N. (2025). Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: A prespecified analysis of the DARE-19 randomized trial. Cardiovascular Diabetology, 24(1), 1. https://doi.org/10.1186/s12933-025-02875-6

Chicago Style (17th ed.) Citation

Abdel Jawad, Mohammad, et al. "Efficacy and Safety of Dapagliflozin in Patients Hospitalized with COVID-19 with and Without Type 2 Diabetes: A Prespecified Analysis of the DARE-19 Randomized Trial." Cardiovascular Diabetology 24, no. 1 (2025): 1. https://doi.org/10.1186/s12933-025-02875-6.

MLA (9th ed.) Citation

Abdel Jawad, Mohammad, et al. "Efficacy and Safety of Dapagliflozin in Patients Hospitalized with COVID-19 with and Without Type 2 Diabetes: A Prespecified Analysis of the DARE-19 Randomized Trial." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12933-025-02875-6.